NEXIEN BIOPHARMA
Nexien BioPharma is proceeding with pre-clinical and clinical drug development activities, in accordance with U.S. Food and Drug Administration ("FDA") protocols, for a number of pharmaceutical formulations that include cannabinoids.
NEXIEN BIOPHARMA
Industry:
Biotechnology Pharmaceutical Robotics
Founded:
2017-01-01
Address:
Denver, Colorado, United States
Country:
United States
Website Url:
http://www.nexienbiopharma.com
Total Employee:
1+
Status:
Active
Contact:
303.495.7583
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics Font Awesome Global Site Tag Mobile Non Scaleable Content
Similar Organizations
Avid Radiopharmaceuticals
Avid Radiopharmaceuticals develops molecular imaging agents for detecting and monitoring chronic human diseases.
Reaction Biology
Reaction Biology is an industry leader and innovator specializing in assay services and protein production for early-stage drug discovery
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-10-30 | CRx Bio | CRx Bio acquired by Nexien BioPharma | N/A |
Official Site Inspections
http://www.nexienbiopharma.com
- Host name: 159.89.138.44
- IP address: 159.89.138.44
- Location: Santa Clara United States
- Latitude: 37.3417
- Longitude: -121.9753
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 95051
More informations about "Nexien BioPharma"
Nexien BioPharma | A Pharmaceutical Cannabinoid Research
Nexien BioPharma operates in strict compliance with United States Drug Enforcement Administration (DEA) licensed pharmaceutical clinical research organizations (CRO's), …See details»
About - Nexien BioPharma
Nexien BioPharma is currently researching and developing proprietary pharmaceutical formulations consisting of different cannabinoids and terpenes.See details»
Management - Nexien BioPharma
Research and Development of Cannabinoid Pharmaceuticals in Accordance with United States Food and Drug Administration (FDA) Regulatory Pathways. Nexien BioPharma is directed and …See details»
Nexien BioPharma - LinkedIn
Developing, licensing and commercializing cannabinoid based medications for specific medical conditions and disorders. | Researchers and Developers of Cannabinoid-Based Pharmaceuticals in...See details»
Nexien BioPharma - Crunchbase Company Profile
Nexien BioPharma develops cannabinoid based medications for specific medical conditions and disorders. View contacts for Nexien BioPharma to access new leads and connect with decision-makers.See details»
Nexien BioPharma Announces Executive and Business Updates
Feb 19, 2019 · Nexien BioPharma is a US-based pharmaceutical company engaged in the formulation, development and commercialization of cannabinoid pharmaceuticals in …See details»
Nexien BioPharma, Inc. Engages CORE IR for Investor Relations, …
Feb 19, 2021 · Nexien BioPharma is a US-based pharmaceutical company engaged in the formulation, development, and commercialization of cannabinoid-based pharmaceuticals in …See details»
Nexien Biopharma Inc, NXEN:PKC profile - FT.com - Financial Times
Oct 11, 2024 · Nexien Biopharma Inc (NXEN:PKC) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.See details»
Contact - Nexien BioPharma
Research and Development of Cannabinoid Pharmaceuticals in Accordance with United States Food and Drug Administration (FDA) Regulatory Pathways. We look forward to hearing from you.See details»
Nexien BioPharma, Inc. (NXEN) - Yahoo Finance
Nexien BioPharma, Inc. focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, drug delivery systems, and related technologies for …See details»
Nexien BioPharma, Inc. Engages CORE IR for Investor
Feb 19, 2021 · CORE IR will focus on expanding market awareness for Nexien and conveying the Company's business model and growth strategies to the institutional and retail investment …See details»
Nexien BioPharma OTCPK:NXEN Stock Report - Simply Wall St
5 days ago · Nexien BioPharma, Inc. focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, drug delivery systems, and related …See details»
NXEN: Nexien BioPharma Inc Stock Price Quote - OTC US
Nexien BioPharma Inc operates as a pharmaceutical development company. The Company researches and develops drugs and cannabinoid molecules for the treatment of vascular …See details»
Advisory Board - Nexien BioPharma
At Nexien BioPharma we have built a trusted group of advisors that work to guide us in our corporate growth. PhD in Clinical Pharmacology from the Leiden University Medical Center. …See details»
Intiva Biopharma - Overview, News & Similar companies - ZoomInfo
View Intiva Biopharma (www.nexienbiopharma.com) location in Colorado, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Nexien BioPharma Engages Dr. Benedikt Schoser as Advisor
DENVER, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Nexien BioPharma Inc. (OTCQB: NXEN) ("Nexien" or the "Company") today announced that it has retained Dr. Benedikt Schoser as an …See details»
Nexien Biopharma | Denver CO - Facebook
Nexien Biopharma, Denver, Colorado. 91 likes. Nexien [Stock Symbol = NXEN] is developing, licensing and commercializing cannabinoid pharmaceuticals for...See details»
Nexien BioPharma | Research and Development
Nexien is developing advanced parenteral formulations and drug delivery systems, as well as precision oral and sublingual tablet technology for the use of cannabinoid API's as standalone …See details»
NXEN Stock Price & Charts | Nexien BioPharma
Nexien BioPharma Inc is a researcher and developer of cannabinoid-based pharmaceutical for various medical conditions and disorders, all under U.S. Food and Drug Administration …See details»
News - Nexien BioPharma
Jan 9, 2019 · Research and Development of Cannabinoid Pharmaceuticals in Accordance with United States Food and Drug Administration (FDA) Regulatory Pathways.See details»